{
    "id": 32561,
    "fullName": "CSF1R W450_E456del",
    "impact": "deletion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CSF1R W450_E456del results in a deletion of seven amino acids within the Ig-like C2 type domain 5 of the Csf1r protein (UniProt.org). W450_E456del confers a gain of function to the Csf1r protein, resulting in cytokine-independent cell growth and increased Mek/Erk signaling in culture (PMID: 31768065).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 17649,
                    "pubMedId": 31768065,
                    "title": "Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31768065"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1436,
        "geneSymbol": "CSF1R",
        "terms": [
            "CSF1R",
            "BANDDOS",
            "C-FMS",
            "CD115",
            "CSF-1R",
            "CSFR",
            "FIM2",
            "FMS",
            "HDLS",
            "M-CSF-R"
        ]
    },
    "variant": "W450_E456del",
    "createDate": "02/10/2020",
    "updateDate": "02/10/2020",
    "referenceTranscriptCoordinates": {
        "id": 187901,
        "transcript": "NM_005211",
        "gDna": "chr5:g.150070015_150070035del21",
        "cDna": "c.1348_1368del21",
        "protein": "p.W450_E456delWDDPYPE",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20319,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing CSF1R W450_E456del demonstrated sensitivity to treatment with Turalio (pexidartinib) in culture (PMID: 31768065).",
            "molecularProfile": {
                "id": 35107,
                "profileName": "CSF1R W450_E456del"
            },
            "therapy": {
                "id": 874,
                "therapyName": "Pexidartinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17649,
                    "pubMedId": 31768065,
                    "title": "Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31768065"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20320,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing CSF1R W450_E456del demonstrated sensitivity to treatment with BLZ945 in culture (PMID: 31768065).",
            "molecularProfile": {
                "id": 35107,
                "profileName": "CSF1R W450_E456del"
            },
            "therapy": {
                "id": 2844,
                "therapyName": "BLZ945",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17649,
                    "pubMedId": 31768065,
                    "title": "Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31768065"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35107,
            "profileName": "CSF1R W450_E456del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 187902,
            "transcript": "NM_001288705",
            "gDna": "chr5:g.150070015_150070035del21",
            "cDna": "c.1348_1368del21",
            "protein": "p.W450_E456delWDDPYPE",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 187901,
            "transcript": "NM_005211",
            "gDna": "chr5:g.150070015_150070035del21",
            "cDna": "c.1348_1368del21",
            "protein": "p.W450_E456delWDDPYPE",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}